Illumina has raised $100 million to detect cancer before it’s too late

How many cancer-related deaths do you think would’ve been avoided if doctors had discovered the cancer sooner? Lots of them, I can assure you. But the problem is, most of the time, doctors only discover that someone has cancer after they start showing symptoms, at which point their chances of survival have probably decreased drastically. That’s where a San Diego-based company by the name of Illumina wants to help. The company claims that it’s developing a new type of blood test that will be able to detect several types of cancer even before symptoms arise for less than $1,000, and it just received $100 million in funding to continue its development.